Authors:
Avinash Singh, Sunita Singh
Download free PDF
Cold Chain Equipment Market Size & Share 2026-2035
Report ID: GMI8475
|
Published Date: September 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Download Free PDF
Explore Our Licensing Options:
Download Free PDF
Cold Chain Equipment Market
Get a free sample of this reportWhat are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.

Cold Chain Equipment Market Size
The global cold chain equipment market was valued at USD 39.5 billion in 2025 and is projected to expand from USD 42.1 billion in 2026 to USD 81.2 billion by 2035, at a CAGR of 7.6%.
Cold Chain Equipment Market Key Takeaways
Market Leader: Hoshizaki Corporation led with over 7.9% market share in 2025.
Leading Players: Top 5 players in this market include Hoshizaki Corporation, Trane Technologies (Thermo King), Carrier Global Corporation, Copeland, Epta Group, which collectively held a market share of 30.9% in 2025.
The market covers demand-side revenue for hardware and integrated systems used to preserve specified temperature conditions across storage, transportation, packaging, and monitoring activities. Cold-chain logistics services, software-only platforms, residential refrigeration, and non-cold-chain industrial process cooling are excluded.
The installed base remains substantial: the Global Cold Chain Alliance reported 719 million cubic meters of cold-storage capacity across 51 countries in its 2020 global capacity assessment [1]Global Cold Chain Alliance, 2020 Global Cold Storage Capacity Report, gcca.org. That installed infrastructure creates a large replacement, retrofit, and monitoring opportunity in addition to greenfield warehouse construction. Demand is increasingly shaped by applications where a temperature excursion can destroy product value rather than merely reduce shelf life, including biologics, vaccines, plasma, cell and gene therapies, and clinical-trial materials.
Biopharma adds a distinct equipment requirement. PhRMA identifies approximately 907 biologic medicines and vaccines in human clinical trials or under FDA review, while more than 85% of biologics require cold-chain storage conditions [2]PhRMA, Medicines in Development: Biologics, phrma.org. Temperature sensitivity is not uniform across these products: product formulation, shipping duration, and exposure to freeze-thaw cycles determine whether chilled, frozen, ultra-low-temperature, or cryogenic equipment is required. Research on biologic product stability also shows why equipment selection increasingly centers on validated temperature performance rather than nominal refrigeration capacity alone.
Food and beverage infrastructure continues to account for the broadest equipment demand, particularly for refrigerated warehouses, cold rooms, display cases, reefers, and last-mile transport refrigeration. Pharmaceutical and biotechnology demand, however, is changing the revenue mix toward monitored assets, specialty packaging, and ultra-low-temperature equipment. This combination supports a market in which the installed base grows through food logistics and organized retail, while value growth is increasingly concentrated in highly specified applications.
GMI Analyst View
The movement from USD 39.5 billion in 2025 to USD 81.2 billion by 2035 reflects more than a volume expansion in cold rooms and transport refrigeration. The market is shifting from a predominantly capacity-led purchase cycle toward a risk-management purchase cycle. Food logistics still requires scale, but pharmaceutical, biotechnology, and regulated food applications increasingly require evidence that a temperature condition was maintained throughout storage and transit.
This changes the economic center of gravity for equipment suppliers. Equipment that captures, communicates, and documents temperature performance can command a more strategic role than equipment sold solely on installed cooling capacity. The fastest growth therefore sits alongside, rather than replaces, conventional storage and transportation demand: large installed assets create the physical cold chain, while monitoring, specialty packaging, and cryogenic systems make that chain usable for higher-value cargo.
Key Drivers
Temperature-sensitive cargo is expanding the value of equipment per shipment
Biologic medicines and vaccines require temperature-controlled handling for a substantial portion of the development and commercial pipeline. This increases demand for validated chilled storage, ultra-low-temperature freezers, cryogenic vessels, active transport units, and qualified passive packaging. The commercial effect is not limited to pharmaceutical manufacturers: specialized logistics providers, hospitals, clinical-research networks, and distributors must purchase equipment that maintains and records product conditions during handoffs.
Food-chain modernization supports a wider physical equipment base.
Cold storage capacity remains uneven across regions, creating demand for refrigerated warehouses, cold rooms, display equipment, transport refrigeration units, and reefer containers. In containerized transport, CIMC reported sales of 138,600 reefer TEUs in 2024, compared with 92,500 units in 2023, a rise of nearly 50%; the company attributed the recovery partly to Red Sea disruptions and port congestion [3]CIMC, Annual Results Announcement 2024, hkexnews.hk. Although container demand is cyclical, the rebound demonstrates how trade disruption can quickly convert limited refrigerated capacity into equipment demand.
Traceability requirements are turning monitoring from an accessory into a procurement criterion.
The U.S. Food and Drug Administration's Food Traceability Rule establishes additional recordkeeping requirements for foods on the Food Traceability List, with the compliance date extended to July 20, 2028 [4]U.S. Food and Drug Administration, Food Traceability Rule, fda.gov. This does not prescribe a specific sensor or platform, but it raises the operational value of equipment able to capture, retain, and retrieve temperature and traceability records. Monitoring systems, data loggers, wireless sensors, and integrated warehouse controls can consequently be specified alongside refrigeration assets rather than added after installation.
Refrigerant transition is creating replacement demand.
Regulation (EU) 2024/573 tightens the EU's fluorinated greenhouse gas framework and establishes a phase-down path for HFCs, accelerating the need to assess refrigerant choices in new and replacement systems. For cold-room operators, supermarkets, and foodservice sites, replacement decisions are increasingly linked to refrigerant availability, energy performance, maintenance capability, and total ownership cost. The result is a longer procurement process but a more durable driver for equipment renewal.
Key Restraints
Capital intensity limits the pace at which capacity shortfalls become equipment orders.
A refrigerated warehouse or sophisticated pharmaceutical storage installation requires refrigeration hardware, insulated construction, controls, backup power, commissioning, qualification, and ongoing maintenance. Small distributors and regional food operators may therefore preserve older equipment longer, choose smaller modular installations, or rely on third-party capacity rather than build dedicated assets. This is particularly relevant in emerging markets where demand for cold-chain capability can exceed available project finance and technical-service coverage.
Energy consumption and technical complexity raise lifetime costs.
Refrigeration systems operate continuously, and their economics depend on load profile, ambient conditions, refrigeration architecture, refrigerant choice, insulation integrity, control calibration, and maintenance quality. More demanding temperature ranges increase the consequence of failure and can require redundancy, alarms, contingency power, and documented qualification. These requirements improve product protection but can discourage adoption where power reliability, technician availability, or energy costs are unfavorable.
Compliance can pull demand forward while increasing project complexity.
FDA traceability requirements and EU refrigerant regulation create reasons to modernize, but they also require operators to assess recordkeeping practices, refrigerant management, controls integration, and service readiness. Equipment manufacturers that can supply compliant systems, documentation, and local service capacity are better positioned than suppliers offering an isolated refrigeration asset. Conversely, operators with weak engineering resources can delay projects while they resolve design, financing, and operational-accountability issues.
GMI Analyst View
The market's central tension is that the same forces raising demand also raise the cost of participation. Food traceability, pharmaceutical qualification, and refrigerant-transition requirements make legacy assets less acceptable, but compliant replacements require more engineering, controls, documentation, and trained maintenance support. The result is not a uniform upgrade cycle: large regulated operators are likely to modernize earlier, while smaller operators may defer capital expenditure or choose simpler configurations.
This tension favors suppliers that reduce the customer's execution burden. A refrigeration manufacturer with monitoring, commissioning support, refrigerant expertise, and service coverage can convert regulatory complexity into a differentiated offer. Suppliers unable to support lifecycle performance risk competing primarily on upfront price, precisely where capital-constrained buyers are most likely to delay investment.
Cold Chain Equipment Market Segment Analysis
Equipment Type
Storage equipment generated USD 18.3 billion in 2025 and is projected to expand at approximately 5.4% CAGR through 2035. Refrigerated warehouses, cold rooms, industrial refrigeration systems, commercial refrigerators, freezers, and ultra-low-temperature storage remain the market's largest equipment base because food processing, retail distribution, pharmaceutical inventory, and healthcare operations require stationary temperature capacity before goods can enter transport networks.
Monitoring and control systems are projected to record the fastest growth among equipment categories, at approximately 13% CAGR. Their growth reflects the increasing cost of temperature excursions and the operational need to document chain-of-custody conditions. In regulated cargo flows, a sensor, data logger, remote alarm, or integrated management system becomes valuable when it permits corrective action before product loss and provides a defensible record after an excursion.
Temperature Range
The chilled range of +2°C to +8°C held 37.9% of the market in 2025. It serves dairy products, produce, vaccines, biologics, and many temperature-sensitive medicines, making it the largest common operating range across food and life-science applications. Cryogenic equipment, while smaller, is projected to grow at approximately 10.1% CAGR as cell and gene therapies, research samples, and biobanking require storage and transit below -80°C. The crucial distinction is that chilled demand is broad and repetitive, whereas cryogenic demand is narrower but more technically demanding and higher specification.
Application
Food and beverages remain the largest application, spanning fruits and vegetables, dairy products, meat, fish and seafood, processed food and ready-to-eat meals, bakery and confectionery, and other perishable goods. Pharmaceuticals require differentiated equipment for vaccines, biologics and biosimilars, temperature-sensitive APIs, and clinical-trial materials. Healthcare demand includes blood products and plasma, organs and tissue for transplantation, and medical supplies and reagents. Biotechnology is projected to be the fastest-growing application at 16.6% CAGR, driven by cell and gene therapies, research samples, and biobanking. These applications require equipment designed for verified temperature stability, not merely standard frozen storage.
GMI Analyst View
The fastest-growing segments point to a redefinition of cold-chain equipment. Monitoring and control systems growing at approximately 13%, passive systems gaining 10 percentage points of share, and biotechnology expanding at 16.6% CAGR indicate that the market is becoming more modular, data-intensive, and cargo-specific. Refrigeration capacity remains essential, but it is increasingly purchased with a requirement for traceability, portability, and validated performance.
For manufacturers, portfolio breadth alone is insufficient. Storage and transportation suppliers need interoperable controls, while packaging providers need qualification capabilities and reuse economics. Manufacturing strategy must accommodate smaller, higher-specification batches for life-science applications alongside standardized scale production for food logistics. The companies best placed to benefit will be those able to translate a temperature requirement into a complete system specification across equipment, monitoring, packaging, and service.
Cold Chain Equipment Market Regional Analysis
North America
North America represented USD 12.72 billion in 2025 and is projected to grow at 6.6% CAGR through 2035. The U.S. market was valued at USD 10.9 billion in 2025 and is projected to expand at approximately 6.8% CAGR. Mature food distribution networks provide a large replacement base, while biologics, clinical materials, and healthcare logistics support demand for higher-specification equipment. The region's traceability environment increases the commercial relevance of monitoring and data-capture capabilities.
Europe
Europe generated USD 10.33 billion in 2025 and is projected to grow at 5.9% CAGR. Germany led the regional market in 2025, supported by its industrial refrigeration base, pharmaceutical manufacturing footprint, and established food logistics infrastructure. The region's growth is shaped less by first-time cold-chain construction than by replacement and retrofit activity. Regulation (EU) 2024/573 creates a regulatory reason to reassess HFC-based systems, placing energy efficiency, natural refrigerants, and service capability at the center of procurement [5]European Union, Regulation (EU) 2024/573 on Fluorinated Greenhouse Gases, eur-lex.europa.eu.
Asia Pacific
Asia Pacific was valued at USD 11.39 billion in 2025 and is projected to expand at 9.3% CAGR, making it the fastest-growing major region. China held 43.2% of Asia Pacific demand in 2025 and is projected to grow at approximately 9.5% CAGR through 2035. The region combines food cold-chain modernization, expanding organized retail and e-commerce logistics, pharmaceutical manufacturing, and refrigerated trade. CIMC's 2024 reefer-container recovery illustrates the region's importance to refrigerated container manufacturing and international cold-chain flows.
Latin America
Latin America accounted for USD 2.75 billion in 2025 and is projected to grow at 9.0% CAGR. Demand is tied to investments in food exports, organized food distribution, temperature-controlled pharmaceutical logistics, and more formalized cold storage networks. Equipment suppliers face a market where project economics, local service coverage, and access to financing can matter as much as product performance.
Middle East & Africa
Middle East & Africa represented USD 2.31 billion in 2025 and is projected to grow at 7.4% CAGR. Saudi Arabia, the UAE, and South Africa are key markets for food-security infrastructure, healthcare logistics, and organized retail. Growth may be uneven because large warehouse and food-security projects can be tender-driven. Suppliers that combine local partnerships, service readiness, and modular equipment configurations are more likely to address this volatility than suppliers dependent solely on large turnkey projects.
GMI Analyst View
Regional growth rates reflect different purchasing mechanisms. Asia Pacific's 9.3% CAGR is led by physical buildout and modernization: buyers require capacity, transport assets, and monitoring as cold-chain networks become more formalized. North America's 6.6% growth is more closely connected to biologics, replacement demand, and traceability-oriented controls. Europe's 5.9% trajectory is shaped by a regulatory replacement cycle in which refrigerant strategy and energy performance influence asset decisions.
Global manufacturers should not apply one capacity strategy across these markets. Asia Pacific warrants localized manufacturing, distribution, and service partnerships capable of addressing broad equipment demand. Europe requires refrigerant-transition expertise and retrofit capability. North America offers opportunities for high-specification monitoring, pharmaceutical handling, and transport-refrigeration upgrades. The commercial advantage lies in matching product configuration and service model to the regional source of demand rather than pursuing scale with a uniform offering.
Cold Chain Equipment Market Share & Competitive Landscape
The market is moderately fragmented. Hoshizaki Corporation led the market in 2025 with a 7.9% share, while the top five companies such as Hoshizaki Corporation, Trane Technologies, Carrier Global Corporation, Copeland, and Epta Group collectively accounted for approximately 30.9%. The limited share held by the leading suppliers reflects the breadth of the market: commercial refrigeration, industrial cold storage, reefer containers, transport refrigeration, specialty packaging, monitoring systems, and cryogenic equipment each have distinct purchase criteria and regional competitive structures.
Hoshizaki Corporation leads the market through its broad portfolio of refrigeration systems, commercial cold storage solutions, and temperature-controlled equipment targeting foodservice, healthcare, and pharmaceutical applications. The company focuses on energy-efficient cooling technologies, operational reliability, and advanced refrigeration performance to strengthen product competitiveness globally.
Trane Technologies, through its Thermo King division, operates in the cold chain equipment market by providing transportation refrigeration systems and temperature-control technologies for logistics and supply chain applications. The company focuses on maintaining temperature integrity throughout food and pharmaceutical transportation while improving fuel efficiency and reducing emissions.
Copeland specializes in refrigeration compressors, monitoring systems, and cold chain technologies designed for industrial refrigeration and temperature-sensitive logistics applications. The company focuses on improving cooling efficiency, equipment performance, and temperature precision across food and pharmaceutical supply chains.
Epta Group operates in the cold chain equipment market through commercial refrigeration systems and integrated cold storage technologies serving retail, foodservice, and logistics industries. The company focuses on environmentally sustainable refrigeration solutions, energy-efficient systems, and customized cooling technologies.
Competition is increasingly determined by the ability to combine refrigerant transition, energy efficiency, connected monitoring, qualified temperature performance, and service coverage. A supplier with a strong product in one category may still require channel partners or system-integration capabilities to compete in projects involving warehouse automation, passive packaging, ultra-low-temperature storage, or fleet telematics.
Recent Industry Developments
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Question(FAQ) :
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →